Lake Street Initiates Coverage On Sanara MedTech with Buy Rating, Announces Price Target of $32
Benzinga Newsdesk 6 months ago
NewsPrice TargetInitiationAnalyst Ratings
Lake Street analyst Frank Takkinen initiates coverage on Sanara MedTech (NASDAQ:SMTI) with a Buy rating and announces Price Target of $32.
Lake Street analyst Frank Takkinen initiates coverage on Sanara MedTech (NASDAQ:SMTI) with a Buy rating and announces Price Target of $32.